Björn Schultze

Björn Schultze (MD) is a resident physician in general medicine. He has been with CTC since 2022 acting as principal investigator and co-investigator in several early phase trials, including first-in-human trials.

Björn has a special interest in dermatology and endocrinology, as well as pediatrics in the open practise setting.